Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
McKesson
Daiichi Sankyo
Fish and Richardson
Cipla
US Department of Justice
Moodys
QuintilesIMS
Harvard Business School

Generated: April 21, 2018

DrugPatentWatch Database Preview

CIBACALCIN Drug Profile

« Back to Dashboard

Which patents cover Cibacalcin, and when can generic versions of Cibacalcin launch?

Cibacalcin is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in CIBACALCIN is calcitonin human. There are fourteen drug master file entries for this compound. Additional details are available on the calcitonin human profile page.
Summary for CIBACALCIN
Drug patent expirations by year for CIBACALCIN

US Patents and Regulatory Information for CIBACALCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis CIBACALCIN calcitonin human INJECTABLE;INJECTION 018470-001 Oct 31, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for CIBACALCIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis CIBACALCIN calcitonin human INJECTABLE;INJECTION 018470-001 Oct 31, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis CIBACALCIN calcitonin human INJECTABLE;INJECTION 018470-001 Oct 31, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Colorcon
Dow
Chubb
Teva
Chinese Patent Office
Cerilliant
Johnson and Johnson
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.